Digest Network Come funziona
Network
/
Società
ne
Non verificato

neuropacs Corp.

Di cosa scriviamo

Attrezzature medico-sanitarieIndustriaSaluteSoftwareTecnica

5 comunicati stampa

Guarda tutti i comunicati
29/09/2026
Mercato del lavoro
Information Technology
Tecnica
Medicina nucleare
Sanità
Attrezzature medico-sanitarie
Medicina - Varie
Biotecnologia
Scienza
Software
Salute
UF-Led Alzheimer’s Research Center Awarded $22 Million to Accelerate Discoveries; Neuropacs CSO David Vaillancourt to Play Key Scientific Leadership Role
Fonte
neuropacs Corp.
Emittente
Business Wire
1.00
0
02/06/2026
Tecnica
Scienza
Attrezzature medico-sanitarie
Software
Salute
Industria
Neuropacs Announces the Publication of a New Study Comparing the First‑of‑Its‑Kind FDA De Novo–Classified Imaging Biomarker for Parkinson’s Disease with CSF Alpha‑Synuclein Seed Amplification Assay
Fonte
neuropacs Corp.
Emittente
Business Wire
1.00
0
07/04/2026
Industria
Biotecnologia
Salute
Igiene alimentare
Attrezzature medico-sanitarie
Tecnica
FDA Grants De Novo Classification to neuropacs™, a First-in-Class AI-Based MRI Diagnostic Aid for Parkinsonian Syndromes
Fonte
neuropacs Corp.
Emittente
Business Wire
1.00
0
20/01/2026
Tecnica
Sanità
Salute
Medicina nucleare
Tecnologie Varie
Software
Neuropacs Closes Seed Round of Financing
Fonte
neuropacs Corp.
Emittente
Business Wire
1.00
0
18/03/2025
Industria
Salute
Tecnica
Software
Medicina - Varie
JAMA Neurology publishes landmark study showing neuropacs™ AI technology significantly enhances the diagnostic accuracy of Parkinson’s disease and atypical parkinsonism
Fonte
neuropacs Corp.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0